Setterwalls has assisted IRRAS in connection with directed share issue

Setterwalls has assisted IRRAS AB in connection with a directed share issue to a number of Swedish and international institutional investors.

The gross proceeds of the share issue amounts to approximately SEK 106 million. IRRAS is a publicly-traded, commercial-stage medical technology company focused on developing and commercializing innovative solutions for brain surgery. For further information about the share issue and IRRAS, please refer to the company’s website.